NCT01123824 - Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Healthy

Interventions

DRUG

CLOPIDOGREL

"Pharmaceutical form: tablets~Route of administration: oral"

DRUG

placebo

"Pharmaceutical form: matching tablets~Route of administration: oral"

Trial Locations (1)

Sanofi-Aventis Administrative Office, Berlin